As someone has pointed out, a number of new investors may be looking into OXB over the break, as a tip for 2007.
Lets not subject them to toomuch bickering.
Some good posts amongst the dross.
My take FWIW:
Trovax hasn't of course produced a general cure for cancer, or anything close. But that wasnt really expected. Its in Phase II trials where the idea is to generate a reliable signal. It a appears to have done that. Furthermore, it has shown consistently positive results across different cancer types, supported by very strong immunogenicity data.
Trovax is intended, as the TRIST trial is designed, to bring benefits to patients whatever treatment they are on.
It looks in good shape to do this in Phase III.